Pear Thera_老虎社区_美港股上老虎

PSG2010
2021-12-10

Pear Therapeutics extends gain after LJ10 LLC disclosed stake. Pear recently closed its business combination with SPAC Thimble Point Acquisition. The combined company, Pear Therapeutics (PEAR), began trading on NASDAQ. The transaction was expected to generate about $175M in gross proceeds.

The rapidly emerging PDT category is building momentum with accelerating clinical validation, patient adoption, prescriber utilization, and payor reimbursement. This is a buy and hold! With this little float i will fly then!$Pear Therapeutics(PEAR)$

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":605104507,"tweetId":"605104507","gmtCreate":1639125137605,"gmtModify":1639125137605,"author":{"id":3479274775305388,"idStr":"3479274775305388","authorId":3479274775305388,"authorIdStr":"3479274775305388","name":"PSG2010","avatar":"https://static.tigerbbs.com/541f6f2cb8479fb86a8d8ef23f482196","vip":8,"userType":8,"introduction":"运营账号","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":28,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>Pear Therapeutics extends gain after LJ10 LLC disclosed stake. Pear recently closed its business combination with SPAC Thimble Point Acquisition. The combined company, Pear Therapeutics (PEAR), began trading on NASDAQ. The transaction was expected to generate about $175M in gross proceeds. The rapidly emerging PDT category is building momentum with accelerating clinical validation, patient adoption, prescriber utilization, and payor reimbursement. This is a buy and hold! With this little float i will fly then!<a href=\"https://laohu8.com/S/PEAR\">$Pear Therapeutics(PEAR)$</a> </body></html>","htmlText":"<html><head></head><body>Pear Therapeutics extends gain after LJ10 LLC disclosed stake. Pear recently closed its business combination with SPAC Thimble Point Acquisition. The combined company, Pear Therapeutics (PEAR), began trading on NASDAQ. The transaction was expected to generate about $175M in gross proceeds. The rapidly emerging PDT category is building momentum with accelerating clinical validation, patient adoption, prescriber utilization, and payor reimbursement. This is a buy and hold! With this little float i will fly then!<a href=\"https://laohu8.com/S/PEAR\">$Pear Therapeutics(PEAR)$</a> </body></html>","text":"Pear Therapeutics extends gain after LJ10 LLC disclosed stake. Pear recently closed its business combination with SPAC Thimble Point Acquisition. The combined company, Pear Therapeutics (PEAR), began trading on NASDAQ. The transaction was expected to generate about $175M in gross proceeds. The rapidly emerging PDT category is building momentum with accelerating clinical validation, patient adoption, prescriber utilization, and payor reimbursement. This is a buy and hold! With this little float i will fly then!$Pear Therapeutics(PEAR)$","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/605104507","repostId":0,"isVote":1,"tweetType":1,"viewCount":1517,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["PEAR"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":466,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}